BIO-GENE TECHNOLOGY LTD — Share Issue/Capital Change 2026

May 25, 2026

Appendix 3B - Proposed issue of securities

Announcement Summary

Entity name
BIO-GENE TECHNOLOGY LTD

Announcement Type
New announcement

Date of this announcement
26/5/2026

The Proposed issue is:
An offer of securities under a securities purchase plan

Total number of +securities proposed to be issued for an offer of securities under a securities purchase plan

ASX +security code	+Security description	Maximum Number of +securities to be issued
New class-code to be confirmed	OPTION EXPIRING 15-OCT-2027 EX $0.035	30,000,000
BGT	ORDINARY FULLY PAID	60,000,000

+Record date
25/5/2026

Offer closing date
19/6/2026

+Issue date
26/6/2026

Refer to next page for full details of the announcement

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

Part 1 - Entity and announcement details

1.1 Name of +Entity

BIO-GENE TECHNOLOGY LTD

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2 Registered Number Type

ABN

Registration Number

32071735950

1.3 ASX issuer code

BGT

1.4 The announcement is

New announcement

1.5 Date of this announcement

26/5/2026

1.6 The Proposed issue is:

An offer of +securities under a +securities purchase plan

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

Part 4 - Details of proposed offer under securities purchase plan

Part 4A - Conditions

4A.1 Do any external approvals need to be obtained or other conditions satisfied before the offer of +securities under the +securities purchase plan issue can proceed on an unconditional basis?
Yes

4A.1a Conditions

Approval/Condition	Date for determination	Is the date estimated or actual?	** Approval received/condition met?
+Security holder approval	31/7/2026	Estimated

Comments
Security holder approval is required for the grant of Attaching Options

Appendix 3B - Proposed issue of securities
3 / 8

---

Appendix 3B - Proposed issue of securities

Part 4B - Offer details

+Class or classes of +securities that will participate in the proposed issue and +class or classes of +securities proposed to be issued

ASX +security code and description

BGT : ORDINARY FULLY PAID

Will the proposed issue of this +security include an offer of attaching +securities?
Yes

Details of +securities proposed to be issued

ASX +security code and description

BGT : ORDINARY FULLY PAID

Maximum total number of those +securities that could be issued if all offers under the +securities purchase plan are accepted
60,000,000

Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)?
No

Will the offer be conditional on applications for a maximum number of +securities being received or a maximum amount being raised (i.e. a maximum subscription condition)?
No

Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)?
Yes

Is the minimum acceptance unit based or dollar based?
Dollar based ($)

Please enter the minimum acceptance value
$ 1,000

Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)?
Yes

Is the maximum acceptance unit based or dollar based?
Dollar based ($)

Please enter the maximum acceptance value
$ 15,000

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

Describe all the applicable parcels available for this offer in number of securities or dollar value

Under the SPP, eligible shareholders may apply for new shares in parcels of A$1,000, A$2,500, A$5,000, A$7,500, A$10,000, A$12,500 or A$15,000

Offer price details

Has the offer price been determined?
Yes

In what currency will the offer be made?
What is the offer price per +security?
AUD - Australian Dollar
AUD 0.02500

Oversubscription & Scale back details

Will a scale back be applied if the offer is over-subscribed?
Yes

Describe the scale back arrangements

Yes, if it exceeds the number of securities allowed under exception 5 of ASX Listing Rule 7.2

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?
Yes

Attaching +Security

The proposed attaching security can only be of an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX)
New class

Attaching +Security - New class (+securities in a class that is not yet quoted or recorded by ASX)

Details of attaching +securities proposed to be issued

ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)

Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1?
No

Will the entity be seeking quotation of the 'new' class of +securities on ASX?
No

ASX +security code	+Security description
New class-code to be confirmed	OPTION EXPIRING 15-OCT-2027 EX $0.035

+Security type
Options

Offer ratio (ratio of attaching securities at which the new +securities will be issued)

The quantity of attaching +securities to be issued
For a given quantity of the new +securities issued
1
2

What will be done with fractional entitlements?
Fractions rounded up to the next whole number

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

Maximum total number of those +securities that could be issued if all offers under the +securities purchase plan are accepted
30,000,000

Offer price details

Has the offer price been determined?
Yes

In what currency will the offer be made?
AUD - Australian Dollar

What is the offer price per +security?
AUD 0.03500

Please confirm whether the offer of the attaching +securities is a separate offer to the offer pursuant to the +security purchase plan
Yes

Please confirm whether the attaching +securities are being offered under a +disclosure document or +PDS
Yes

Oversubscription & Scale back details

Will a scale back be applied if the offer is over-subscribed?
Yes

Describe the scale back arrangements
Yes, if it exceeds the number of securities allowed under exception 5 of ASX Listing Rule 7.2

Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes

Options details

+Security currency
AUD - Australian Dollar

Exercise price
AUD 0.0350

Expiry date
15/10/2027

Details of the type of +security that will be issued if the option is exercised
BGT : ORDINARY FULLY PAID

Number of securities that will be issued if the option is exercised
One (1) share for each option exercised

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement.
The material terms of the options will be provided in a Prospectus expected to be lodged with ASX on 2 June 2026.

Part 4C - Timetable

4C.1 Date of announcement of +security purchase plan
26/5/2026

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

4C.2 +Record date
25/5/2026

4C.3 Date on which offer documents will be made available to investors
2/6/2026

4C.4 Offer open date
2/6/2026

4C.5 Offer closing date
19/6/2026

4C.7 +Issue date and last day for entity to announce results of +security purchase plan offer
26/6/2026

Part 4D - Listing Rule requirements

4D.1 Does the offer under the +securities purchase plan meet all of the requirements of listing rule 7.2 exception 5 or do you have a waiver from those requirements?
Yes

Part 4E - Fees and expenses

4E.1 Will there be a lead manager or broker to the proposed offer?
No

4E.2 Is the proposed offer to be underwritten?
Yes

4E.2a Who are the underwriter(s)?
Dr Choon Huat Lee

4E.2b What is the extent of the underwriting (ie the amount or proportion of the issue that is underwritten)?
The underwriting agreement is in relation to the initial $500,000 raised under the SPP

4E.2c What fee, commission or other consideration is payable to them for acting as underwriter(s)?
Cash fee of $30,000

4E.2d Please provide a summary of the significant events that could lead to the underwriting being terminated.
None

4E.2e Is a party referred to in listing rule 10.11 underwriting or sub-underwriting the proposed offer?
No

4E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission?
No

4E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer
None

Appendix 3B - Proposed issue of securities

---

Appendix 3B - Proposed issue of securities

Part 4F - Further Information

4F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue
To further regulatory studies required to develop Flavocide and Qcide production and working capital.

4F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful?
No

4F.2 Countries in which the entity has +security holders who will not be eligible to accept the proposed offer
Only security holders of Australia will be eligible for the proposed offer.

4F.3 URL on the entity's website where investors can download information about the proposed offer
bio-gene.com.au

4F.4 Any other information the entity wishes to provide about the proposed offer
No

Appendix 3B - Proposed issue of securities
8 / 8